{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:14:41Z","timestamp":1786986881967,"version":"build-2736575974"},"reference-count":66,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.clinthera.2018.03.009","type":"journal-article","created":{"date-parts":[[2018,4,6]],"date-time":"2018-04-06T10:17:28Z","timestamp":1523009848000},"page":"894-902","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Recent Advances in the Pathogenesis of Mucormycoses"],"prefix":"10.1016","volume":"40","author":[{"given":"George","family":"Petrikkos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantinos","family":"Tsioutis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2018.03.009_bib1","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1093\/cid\/cir866","article-title":"Epidemiology and clinical manifestations of mucormycosis","volume":"54","author":"Petrikkos","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2018.03.009_bib2","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.2217\/fmb.13.78","article-title":"Epidemiology and treatment of mucormycosis","volume":"8","author":"Lewis","year":"2013","journal-title":"Future Microbiol"},{"key":"10.1016\/j.clinthera.2018.03.009_bib3","doi-asserted-by":"crossref","unstructured":"Baldin C, Ibrahim AS. Molecular mechanisms of mucormycosis\u2014the bitter and the sweet. Sheppard DC, ed. PLOS Pathog. 2017;13:e1006408.","DOI":"10.1371\/journal.ppat.1006408"},{"key":"10.1016\/j.clinthera.2018.03.009_bib4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.idc.2015.10.011","article-title":"Mucormycoses","volume":"30","author":"Farmakiotis","year":"2016","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.clinthera.2018.03.009_bib5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/myc.12235","article-title":"Interaction of Zygomycetes with innate immune cells reconsidered with respect to ecology, morphology, evolution and infection biology: a mini-review","volume":"57","author":"Park","year":"2014","journal-title":"Mycoses"},{"key":"10.1016\/j.clinthera.2018.03.009_bib6","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1080\/21505594.2017.1364335","article-title":"Mucormycosis pathogenesis: beyond rhizopus","volume":"8","author":"Spellberg","year":"2017","journal-title":"Virulence"},{"key":"10.1016\/j.clinthera.2018.03.009_bib7","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1080\/21505594.2017.1360460","article-title":"Ketoacidosis alone does not predispose to mucormycosis by Lichtheimia in a murine pulmonary infection model","volume":"8","author":"Schulze","year":"2017","journal-title":"Virulence"},{"key":"10.1016\/j.clinthera.2018.03.009_bib8","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/1469-0691.12466","article-title":"Why is mucormycosis more difficult to cure than more common mycoses?","volume":"20","author":"Katragkou","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.clinthera.2018.03.009_bib9","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/j.1469-0691.2010.03456.x","article-title":"Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on zygomycosis between 2005 and 2007","volume":"17","author":"Skiada","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.clinthera.2018.03.009_bib10","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: a review of 929 reported cases","volume":"41","author":"Roden","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2018.03.009_bib11","doi-asserted-by":"crossref","first-page":"e2011012","DOI":"10.4084\/mjhid.2011.012","article-title":"Zygomycosis in immunocompromised non-haematological patients","volume":"3","author":"Petrikkos","year":"2011","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.clinthera.2018.03.009_bib12","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.clindermatol.2012.01.010","article-title":"Global epidemiology of cutaneous zygomycosis","volume":"30","author":"Skiada","year":"2012","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clinthera.2018.03.009_bib13","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1093\/cid\/cir865","article-title":"Pathogenesis of mucormycosis","volume":"54","author":"Ibrahim","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2018.03.009_bib14","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/myc.12236","article-title":"Pathogenesis and host defence against Mucorales: the role of cytokines and interaction with antifungal drugs","volume":"57","author":"Roilides","year":"2014","journal-title":"Mycoses"},{"key":"10.1016\/j.clinthera.2018.03.009_bib15","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/590004","article-title":"Delaying amphotericin B\u2013based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis","volume":"47","author":"Chamilos","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2018.03.009_bib16","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/1469-0691.12566","article-title":"Mucormycosis: from the pathogens to the disease","volume":"20","author":"Binder","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.clinthera.2018.03.009_bib17","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.imbio.2012.10.013","article-title":"Rhizopus oryzae hyphae are damaged by human natural killer (NK) cells, but suppress NK cell mediated immunity","volume":"218","author":"Schmidt","year":"2013","journal-title":"Immunobiology"},{"key":"10.1016\/j.clinthera.2018.03.009_bib18","doi-asserted-by":"crossref","unstructured":"Ma L-J, Ibrahim AS, Skory C, et al. Genomic analysis of the basal lineage fungus rhizopus oryzae reveals a whole-genome duplication. Madhani HD, ed. PLoS Genet. 2009;5:e1000549.","DOI":"10.1371\/journal.pgen.1000549"},{"key":"10.1016\/j.clinthera.2018.03.009_bib19","article-title":"ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients","author":"Tissot","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.clinthera.2018.03.009_bib20","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1128\/CMR.13.2.236-301.2000","article-title":"Zygomycetes in human disease","volume":"13","author":"Ribes","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.clinthera.2018.03.009_bib21","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/S0140-6736(03)14904-5","article-title":"Glucocorticoids and invasive fungal infections","volume":"362","author":"Lionakis","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2018.03.009_bib22","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1093\/cid\/cir869","article-title":"Host defenses against Zygomycetes","volume":"54","author":"Roilides","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2018.03.009_bib23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.mib.2017.10.010","article-title":"The mucormycete\u2013host interface","volume":"40","author":"Ibrahim","year":"2017","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.clinthera.2018.03.009_bib24","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1128\/AAC.01136-07","article-title":"Zygomycetes hyphae trigger an early, robust proinflammatory response in human polymorphonuclear neutrophils through Toll-Like receptor 2 induction but display relative resistance to oxidative damage","volume":"52","author":"Chamilos","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2018.03.009_bib25","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1172\/JCI82744","article-title":"Bicarbonate correction of ketoacidosis alters host-pathogen interactions and alleviates mucormycosis","volume":"126","author":"Gebremariam","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinthera.2018.03.009_bib26","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1086\/428503","article-title":"Interferon-\u03b3 and granulocyte-macrophage colony-stimulating factor augment the activity of polymorphonuclear leukocytes against medically important Zygomycetes","volume":"191","author":"Gil-Lamaignere","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clinthera.2018.03.009_bib27","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1086\/320767","article-title":"Resolution of rhinocerebral zygomycosis associated with adjuvant administration of granulocyte-macrophage colony-stimulating factor","volume":"32","author":"Garcia-Diaz","year":"2001","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.clinthera.2018.03.009_bib28","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/BF01691218","article-title":"Role of granulocyte colony-stimulating factor in the treatment of mucormycosis","volume":"15","author":"Sahin","year":"1996","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.clinthera.2018.03.009_bib29","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3324\/haematol.2012.065110","article-title":"Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3)","volume":"98","author":"Skiada","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.clinthera.2018.03.009_bib30","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2169\/internalmedicine.53.1366","article-title":"Successful treatment of invasive zygomycosis based on a prompt diagnosis using molecular methods in a patient with acute myelogenous leukemia","volume":"53","author":"Yuda","year":"2014","journal-title":"Intern Med Tokyo Jpn"},{"key":"10.1016\/j.clinthera.2018.03.009_bib31","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00520-005-0910-8","article-title":"Secondary prophylaxis of invasive fungal infections with combination antifungal therapy and G-CSF-mobilized granulocyte transfusions in three children with hematological malignancies","volume":"14","author":"Grigull","year":"2006","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.clinthera.2018.03.009_bib32","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1002\/cncr.21929","article-title":"Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions","volume":"106","author":"Safdar","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.clinthera.2018.03.009_bib33","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1160\/TH14-01-0074","article-title":"Platelet immunology in fungal infections","volume":"112","author":"Speth","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.clinthera.2018.03.009_bib34","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/nri2956","article-title":"Platelets and the immune continuum","volume":"11","author":"Semple","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.clinthera.2018.03.009_bib35","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/09537104.2012.678426","article-title":"Bidirectional crosstalk between platelets and monocytes initiated by Toll-like receptor: an important step in the early defense against fungal infections?","volume":"24","author":"Bruserud","year":"2013","journal-title":"Platelets"},{"key":"10.1016\/j.clinthera.2018.03.009_bib36","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1086\/605607","article-title":"Potential antifungal effects of human platelets against Zygomycetes in vitro","volume":"200","author":"Perkhofer","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clinthera.2018.03.009_bib37","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.bbmt.2009.01.019","article-title":"Natural killer cells in allogeneic transplantation: effect on engraftment, graft- versus-tumor, and graft-versus-host responses","volume":"15","author":"Gill","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.clinthera.2018.03.009_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01623","article-title":"Natural killer cells in antifungal immunity","volume":"8","author":"Schmidt","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.clinthera.2018.03.009_bib39","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/myc.12431","article-title":"Natural killer cell-mediated damage of clinical isolates of mucormycetes","volume":"59","author":"Schmidt","year":"2016","journal-title":"Mycoses"},{"key":"10.1016\/j.clinthera.2018.03.009_bib40","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1126\/science.1068440","article-title":"Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants","volume":"295","author":"Ruggeri","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.clinthera.2018.03.009_bib41","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/21505594.2015.1009732","article-title":"Iron starvation induces apoptosis in Rhizopus oryzae in vitro","volume":"6","author":"Shirazi","year":"2015","journal-title":"Virulence"},{"key":"10.1016\/j.clinthera.2018.03.009_bib42","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0022-2143(99)90066-5","article-title":"Ferritin-associated iron induces neutrophil dysfunction in hemosiderosis","volume":"133","author":"Cantinieaux","year":"1999","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.clinthera.2018.03.009_bib43","doi-asserted-by":"crossref","first-page":"134","DOI":"10.5414\/CNP58134","article-title":"Impact of iron dextran on polymorphonuclear cell function among hemodialysis patients","volume":"58","author":"Guo","year":"2002","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.clinthera.2018.03.009_bib44","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1079\/BJN19940094","article-title":"The effects of iron deficiency and iron overload on cell-mediated immunity in the mouse","volume":"72","author":"Omara","year":"1994","journal-title":"Br J Nutr"},{"key":"10.1016\/j.clinthera.2018.03.009_bib45","doi-asserted-by":"crossref","first-page":"e1004842","DOI":"10.1371\/journal.ppat.1004842","article-title":"Fob1 and Fob2 proteins are virulence determinants of Rhizopus oryzae via facilitating iron uptake from ferrioxamine","volume":"11","author":"Liu","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.clinthera.2018.03.009_bib46","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/jac\/dkl350","article-title":"Deferiprone iron chelation as a novel therapy for experimental mucormycosis","volume":"58","author":"Ibrahim","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clinthera.2018.03.009_bib47","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1172\/JCI32338","article-title":"The iron chelator deferasirox protects mice from mucormycosis through iron starvation","volume":"117","author":"Ibrahim","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinthera.2018.03.009_bib48","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1128\/AAC.00361-09","article-title":"Safety and outcomes of open-label deferasirox iron chelation therapy for Mucormycosis","volume":"53","author":"Spellberg","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2018.03.009_bib49","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/jac\/dkr375","article-title":"The Deferasirox\u2013AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial","volume":"67","author":"Spellberg","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clinthera.2018.03.009_bib50","first-page":"169","article-title":"Cloning and functional characterization of the Rhizopus oryzae high affinity iron permease (rFTR1) gene","volume":"235","author":"Fu","year":"2004","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.clinthera.2018.03.009_bib51","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-2958.2010.07234.x","article-title":"The high affinity iron permease is a key virulence factor required for Rhizopus oryzae pathogenesis: FTR1 and mucormycosis virulence","volume":"77","author":"Ibrahim","year":"2010","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.clinthera.2018.03.009_bib52","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1172\/JCI71349","article-title":"CotH3 mediates fungal invasion of host cells during mucormycosis","volume":"124","author":"Gebremariam","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinthera.2018.03.009_bib53","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1172\/JCI42164","article-title":"The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice","volume":"120","author":"Liu","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinthera.2018.03.009_bib54","doi-asserted-by":"crossref","first-page":"12218","DOI":"10.1038\/ncomms12218","article-title":"An integrated genomic and transcriptomic survey of mucormycosis-causing fungi","volume":"7","author":"Chibucos","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.clinthera.2018.03.009_bib55","doi-asserted-by":"crossref","unstructured":"Shirazi F, Farmakiotis D, Yan Y, et al. Diet modification and metformin have a beneficial effect in a fly model of obesity and Mucormycosis. Luque RM, ed. PLoS ONE. 2014;9:e108635.","DOI":"10.1371\/journal.pone.0108635"},{"key":"10.1016\/j.clinthera.2018.03.009_bib56","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1469-0691.2009.02988.x","article-title":"Voriconazole-associated zygomycosis: a significant consequence of evolving antifungal prophylaxis and immunosuppression practices?","volume":"15","author":"Pongas","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.clinthera.2018.03.009_bib57","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1086\/597615","article-title":"Increased virulence of Zygomycetes organisms following exposure to voriconazole: a study involving fly and murine models of zygomycosis","volume":"199","author":"Lamaris","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clinthera.2018.03.009_bib58","doi-asserted-by":"crossref","first-page":"348","DOI":"10.4161\/viru.2.4.17074","article-title":"Voriconazole pre-exposure selects for breakthrough mucormycosis in a mixed model of Aspergillus fumigatus\u2013Rhizopus oryzae pulmonary infection","volume":"2","author":"Lewis","year":"2011","journal-title":"Virulence"},{"key":"10.1016\/j.clinthera.2018.03.009_bib59","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1128\/EC.00138-13","article-title":"The calcineurin pathway inhibitor tacrolimus enhances the in vitro activity of azoles against Mucorales via apoptosis","volume":"12","author":"Shirazi","year":"2013","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.clinthera.2018.03.009_bib60","doi-asserted-by":"crossref","unstructured":"Lee SC, Li A, Calo S, Heitman J. Calcineurin plays key roles in the dimorphic transition and virulence of the human pathogenic zygomycete Mucor circinelloides. Andrianopoulos A, ed. PLoS Pathog. 2013;9:e1003625.","DOI":"10.1371\/journal.ppat.1003625"},{"key":"10.1016\/j.clinthera.2018.03.009_bib61","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/jac\/dkq020","article-title":"In vitro interaction of posaconazole with calcineurin inhibitors and sirolimus against z","volume":"65","author":"Narreddy","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clinthera.2018.03.009_bib62","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/01.TP.0000117252.75651.D6","article-title":"Antifungal attributes of immunosuppressive agents: new paradigms in management and elucidating the pathophysiologic basis of opportunistic mycoses in organ transplant recipients1","volume":"77","author":"Singh","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.clinthera.2018.03.009_bib63","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/infdis\/jis767","article-title":"Tacrolimus enhances the potency of posaconazole against Rhizopus oryzae in vitro and in an experimental model of mucormycosis","volume":"207","author":"Lewis","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clinthera.2018.03.009_bib64","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0272-6386(95)90662-2","article-title":"Apophysomyces elegans infection in a renal transplant recipient","volume":"26","author":"Naguib","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.clinthera.2018.03.009_bib65","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1128\/AAC.50.1.96-103.2006","article-title":"Lovastatin has significant activity against Zygomycetes and interacts synergistically with voriconazole","volume":"50","author":"Chamilos","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2018.03.009_bib66","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/infdis\/jiw090","article-title":"Statin concentrations below the minimum inhibitory concentration attenuate the virulence of Rhizopus oryzae","volume":"214","author":"Bellanger","year":"2016","journal-title":"J Infect Dis"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291818301024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291818301024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T03:47:26Z","timestamp":1571024846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291818301024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":66,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0149291818301024"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2018.03.009","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent Advances in the Pathogenesis of Mucormycoses","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2018.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}